Aurora Cannabis (ACB) Competitors $5.22 -0.12 (-2.25%) Closing price 04:00 PM EasternExtended Trading$5.26 +0.04 (+0.67%) As of 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACB vs. BGM, AUPH, WVE, GYRE, PAHC, MLYS, COLL, SNDX, RCUS, and ELVNShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Qilian International Holding Group (BGM), Aurinia Pharmaceuticals (AUPH), Wave Life Sciences (WVE), Gyre Therapeutics (GYRE), Phibro Animal Health (PAHC), Mineralys Therapeutics (MLYS), Collegium Pharmaceutical (COLL), Syndax Pharmaceuticals (SNDX), Arcus Biosciences (RCUS), and Enliven Therapeutics (ELVN). These companies are all part of the "pharmaceutical products" industry. Aurora Cannabis vs. Qilian International Holding Group Aurinia Pharmaceuticals Wave Life Sciences Gyre Therapeutics Phibro Animal Health Mineralys Therapeutics Collegium Pharmaceutical Syndax Pharmaceuticals Arcus Biosciences Enliven Therapeutics Aurora Cannabis (NASDAQ:ACB) and Qilian International Holding Group (NASDAQ:BGM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, community ranking, media sentiment, earnings, risk and institutional ownership. Which has more volatility & risk, ACB or BGM? Aurora Cannabis has a beta of 1.94, indicating that its stock price is 94% more volatile than the S&P 500. Comparatively, Qilian International Holding Group has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Which has higher valuation and earnings, ACB or BGM? Qilian International Holding Group has lower revenue, but higher earnings than Aurora Cannabis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$320.81M0.91-$48.62M$0.05104.40Qilian International Holding Group$25.10M47.65-$1.44MN/AN/A Does the media favor ACB or BGM? In the previous week, Aurora Cannabis had 1 more articles in the media than Qilian International Holding Group. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Qilian International Holding Group. Aurora Cannabis' average media sentiment score of 0.81 beat Qilian International Holding Group's score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Overall Sentiment Aurora Cannabis Positive Qilian International Holding Group Neutral Do analysts recommend ACB or BGM? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor ACB or BGM? Aurora Cannabis received 384 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformAurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% Qilian International Holding GroupN/AN/A Do institutionals and insiders believe in ACB or BGM? 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 58.7% of Qilian International Holding Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is ACB or BGM more profitable? Aurora Cannabis has a net margin of 0.42% compared to Qilian International Holding Group's net margin of 0.00%. Aurora Cannabis' return on equity of 0.59% beat Qilian International Holding Group's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis0.42% 0.59% 0.42% Qilian International Holding Group N/A N/A N/A SummaryAurora Cannabis beats Qilian International Holding Group on 12 of the 15 factors compared between the two stocks. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$293.44M$1.16B$5.35B$8.38BDividend YieldN/AN/A5.22%4.10%P/E Ratio104.4210.4326.5819.71Price / Sales0.918.65391.69116.98Price / Cash26.3510.4038.2534.62Price / Book0.641.496.794.50Net Income-$48.62M-$54.34M$3.23B$248.18M7 Day Performance3.57%2.96%4.03%1.14%1 Month Performance24.29%12.10%12.50%15.19%1 Year Performance-26.79%-37.42%16.73%6.55% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.6152 of 5 stars$5.22-2.2%N/A-27.8%$293.44M$320.81M104.421,340News CoverageBGMQilian International Holding GroupN/A$11.42+3.5%N/AN/A$1.11B$25.10M0.00298Positive NewsGap UpAUPHAurinia Pharmaceuticals2.4527 of 5 stars$8.12+1.5%$11.50+41.6%+43.6%$1.11B$235.13M-54.13300WVEWave Life Sciences4.4076 of 5 stars$6.60+0.2%$21.17+220.7%+2.5%$1.02B$108.30M-5.95240Positive NewsGap DownGYREGyre Therapeutics0.2757 of 5 stars$10.83+13.6%N/A-21.0%$1.02B$105.76M541.5040PAHCPhibro Animal Health3.5291 of 5 stars$24.50+9.0%$20.00-18.4%+32.1%$992.32M$1.11B51.041,860Positive NewsMLYSMineralys Therapeutics2.7745 of 5 stars$15.01+2.5%$33.00+119.9%+25.7%$973.79MN/A-4.1228COLLCollegium Pharmaceutical4.0712 of 5 stars$29.56+2.3%$43.80+48.2%-12.3%$949.82M$631.45M12.74210News CoveragePositive NewsSNDXSyndax Pharmaceuticals3.8418 of 5 stars$10.99+2.7%$35.91+226.7%-47.8%$945.66M$43.72M-3.03110Positive NewsRCUSArcus Biosciences3.5699 of 5 stars$8.82+6.5%$25.67+191.2%-47.4%$933.38M$141M-2.80500Positive NewsGap DownHigh Trading VolumeELVNEnliven Therapeutics2.5053 of 5 stars$19.01+3.2%$40.33+112.2%-27.6%$932.75MN/A-10.0150Earnings ReportAnalyst RevisionGap Up Related Companies and Tools Related Companies Qilian International Holding Group Competitors Aurinia Pharmaceuticals Competitors Wave Life Sciences Competitors Gyre Therapeutics Competitors Phibro Animal Health Competitors Mineralys Therapeutics Competitors Collegium Pharmaceutical Competitors Syndax Pharmaceuticals Competitors Arcus Biosciences Competitors Enliven Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACB) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACB Stock Free ACB Stock Alerts